Improved clinical response from neoadjuvant taxane chemotherapy across breast cancer subtypes

被引：0
|
作者：
Jenkins, E. O. [1 ]
Deal, A. M. [1 ]
Burrows, E. [1 ]
Drobish, A. [1 ]
Carey, L. A. [1 ]
机构：
[1] Univ N Carolina, Chapel Hill, NC USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
576
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Taxane-based chemotherapy enhances response to neoadjuvant treatment for stage II and III breast cancer
    Andrade, J. M.
    Carrara, H. H. A.
    Pimentel, F. F.
    Marana, H. R. C.
    Macchetti, A. H.
    Mouro, L. R.
    Zola, F. E.
    Tiezzi, D. G.
    MEDICAL ONCOLOGY, 2011, 28 : S65 - S69
  • [32] Taxane-based chemotherapy enhances response to neoadjuvant treatment for stage II and III breast cancer
    J. M. Andrade
    H. H. A. Carrara
    F. F. Pimentel
    H. R. C. Marana
    A. H. Macchetti
    L. R. Mouro
    F. E. Zola
    D. G. Tiezzi
    Medical Oncology, 2011, 28 : 65 - 69
  • [33] Clinical Usefulness of AJCC Response Criteria for Neoadjuvant Chemotherapy in Breast Cancer
    Bhumsuk Keam
    Seock-Ah Im
    Yoojoo Lim
    Sae-Won Han
    Hyeong-Gon Moon
    Do-Youn Oh
    Nariya Cho
    Se-Hoon Lee
    Wonshik Han
    Woo Kyung Moon
    Dong-Wan Kim
    Tae-You Kim
    In Ae Park
    Dong-Young Noh
    Annals of Surgical Oncology, 2013, 20 : 2242 - 2249
  • [34] VARIATION IN RESPONSE TO NEOADJUVANT CHEMOTHERAPY ACROSS WHO HISTOLOGICAL SUBTYPES OF THYMOMA
    Tsukazan, Maria Teresa Ruiz
    Oseran, Andrew
    Baldessare, Randall
    Ding, Jia Jennifer
    Litvak, Anya
    Riely, Gregory J.
    Huang, James
    JOURNAL OF THORACIC ONCOLOGY, 2014, 9 (10) : S223 - S223
  • [35] Clinical Usefulness of AJCC Response Criteria for Neoadjuvant Chemotherapy in Breast Cancer
    Keam, Bhumsuk
    Im, Seock-Ah
    Lim, Yoojoo
    Han, Sae-Won
    Moon, Hyeong-Gon
    Oh, Do-Youn
    Cho, Nariya
    Lee, Se-Hoon
    Han, Wonshik
    Moon, Woo Kyung
    Kim, Dong-Wan
    Kim, Tae-You
    Park, In Ae
    Noh, Dong-Young
    ANNALS OF SURGICAL ONCOLOGY, 2013, 20 (07) : 2242 - 2249
  • [36] Efficacy of Neoadjuvant Chemotherapy in Lobular and Rare Subtypes of Breast Cancer
    Seber, Erdogan Selcuk
    Iriagac, Yakup
    Cavdar, Eyyup
    Karaboyun, Kubilay
    Avci, Okan
    Yolcu, Ahmet
    Gurdal, Sibel Ozkan
    Oznur, Meltem
    Ekinci, Ferhat
    Aytac, Ali
    Gulturk, Ilkay
    Yilmaz, Mesut
    Sever, Nadiye
    Kapagan, Tanju
    Ferhatoglu, Ferhat
    Kahvecioglu, Fatma Akdag
    Hacibekiroglu, Ilhan
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2024, 34 (01): : 37 - 41
  • [37] Molecular subtypes in patients with breast cancer that received neoadjuvant chemotherapy
    Marta, G.
    Mano, M.
    Oliveira, L.
    Pereira, A.
    RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S504 - S504
  • [38] Clinical and pathologic response following taxane based neoadjuvant chemotherapy in locally advanced breast cancer patients in a tertiary care centre in India
    Sivasanker, Masillamany
    Sistla, S. C.
    Ali, Manwar S.
    Vivekanandam, S.
    INDIAN JOURNAL OF CANCER, 2016, 53 (02) : 220 - 225
  • [39] Vitamin D deficiency in various breast cancer subtypes and its impact on response to neoadjuvant chemotherapy in operable breast cancer
    Raman, R.
    Link, B. K.
    Mott, S. L.
    Schroeder, M. C.
    Thomas, A.
    CANCER RESEARCH, 2016, 76
  • [40] Prediction of breast cancer response to neoadjuvant chemotherapy in different biological breast cancer subtypes using diffuse optical tomography
    Altoe, Mirella L.
    Kalinsky, Kevin M.
    Guo, Hua
    Hibshoosh, Hanina
    Tejada, Mariella
    Crew, Katherine D.
    Accordino, Melissa K.
    Trivedi, Meghna S.
    Marone, Alessandro
    Kim, Hyun K.
    Hielscher, Andreas H.
    Hershman, Dawn L.
    CANCER RESEARCH, 2022, 82 (04)
12345